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Abstract
Objectives:. Treatment of childhood NPC similar to adults con-
sists of radiotherapy and chemotherapy, but distant failure is often 
observed, which led to introducing the induction chemotherapy fol-
lowed by radiation or chemoradiation. The improved survival rates 
raised the question of late toxicity. The options for lowering the 
toxicity rate is the application of advanced radiotherapy techniques 
like IMRT and VMAT, and deescalation of the radiation dose in good 
responders and early NPC. 
Case report: We report a case of13-years old male patient with 
a high-risk childhood undifferentiated NPC, stage cT4 cN2b M0. 
He presented with unilateral swallowing at the middle third ofleft 
muscle sterenocleidomastoideus, and headache, fever, sore throat 
and intermittent nasal bleeding for an year. Diagnostic MRI and 
PET/CT showed good concordance for primary tumor extension 
and lymph node involvement. Three coursesinduction chemotherapy 
were applied according to NPC2003-GPOH protocolwith good treat-
ment response. The restaging PET/CT found no distant metastasis.
Deescalatedprotocol of radiotherapy alone was delivered to 50.4 Gy 
total dose with IGRT, VMAT irradiation technique. At three month 
PET/CT follow up a solitary bone lesion was detected
Conclusion: The present case proved that in high risk patients 
more aggressive treatment strategies should be recommended with 
no omission of concurrent chemotherapy even after full response. 
Deescalation of radiotherapy dose probably is not appropriate in this 
group of patients. MRI and PET CT should be used as complemen-
tary imaging modalities for early detection of locoregional or distant 
metastasis.
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Introduction
The incidence of nasopharyngeal carcinoma (NPC) 
in children worldwide is low. Most of the chil-
dren are diagnosed with undifferentiated NPC in 
advanced stage - locoregional or metastatic [1]. 
Childhood NPC is very rare disease and in Bul-
garia. According to the Bulgarian National Cancer 
Registry for the years 2014-2015 only one case in 
the age range 0-14 years is recorded and it was a 
male patient [2].
Treatment of childhood NPC similar to adults con-
sists of radiotherapy and chemotherapy. Different 
regimens have been explored like single modality 
radiotherapy, combined modality or consequen-
tial treatment [3]. High dose radiotherapy alone 
in children achieves 30-60% cure [1, 3].Distant 
failure is often observed in children, which led to 
introducing the induction chemotherapy followed 
by radiation or chemoradiation [4, 5]. The reported 
5 year survival rates reached 70-90% [6]. Improv-
ing cure rates with multimodality therapy raises the 
question of late toxicity [6].One way of lowering 
the toxicity rate is the application of modern radio-
therapy techniques like IMRT and VMAT. Another 
option is the deescalation of the radiation dose in 
good responders and early NPC [4-6].
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There are no clear international consensus to guide 
the daily clinical practice, especially in countries 
with low incidence of childhood NPC.
The aim of the present article is to report the first 
case of childhood NPC, treated at Radiotherapy 
Department, University Hospital Saint Marina, 
Varna, Bulgaria.
Case presentation
A 13-year-old male child presented with unilat-
eral swallowing at the middle third ofleft muscle 
sterenocleidomastoideus, which was preceded by 
complains ofheadache, fever, sore throat and inter-
mittent nasal bleeding for an year. At outpatient 
basis different antibiotics treatment was given with 
temporary or no effect. In march 2017 CT enhanced 
scan of head and neck region revealed left retrobul-
bar tumor formation with infiltration of ethmoidal 
and sphenoidal sinuses and nasopharynx. The 
ophthalmological exam revealed left exophthalmos 
with preserved vision. At ENT physical examina-
tion found a polypoid mass of nasopharynx. A 
biopsy of the formation confirmed undifferenti-
ated carcinoma, with positive immunohistochem-
istry for CK5/6, and negative for CK7 expression. 
Further imaging studies were performed -MRI of 
head and neck and FDG PET/CT and the tumor 
was staged cT4cN2bcM0. The MRI examination 
showed tumor formation in nasopharynx, with 
expansion to sphenoid sinus, left ethmoidal cells, 
middle nasal cavity, left orbit and left parapharyn-
geal space. In the left orbit the tumor dislocated 
in upper direction the lower straight and oblique-
muscles and the optic nerve. Bilateral lymph node 
involvement with biggest mass described at right 
level IIb 37x 20mm was seen (Fig. 1). The staging 
PET/CT scan confirmed the tumor extension and 
lymph node involvement, with no distant metas-
tasis spread (Fig. 2). At tumor board the potential 
treatment related risks were discussed and was 
taken decision the treatment to start with induction 
chemotherapy, followed by radiation or chemora-
diation based on treatment response. According to 
NPC2003-GPOH protocol three courses of induc-
tion chemotherapy with a single dose Cisplatin 80 
mg/m2 at day1 and continuous infusion of 1000 
mg/m25-FU every day for days 1-5 were applied, 
and folinic acid. The control MRI found consider-
able reduction of the tumor mass in all areas of 
involvement (Fig. 3). The control PET-CT revealed 
full treatment response with no metabolic active 
lesions and described persistence of soft tissue 
thickening with no metabolic activity at sphenoid 
sinus, left ethmoidal cells, posterior wall of left 
maxillary sinus (Fig. 4.).
Patient was discussed again at tumor board and 
based on good treatment response of induction che-
motherapy and severe hematological toxicity was 
decided the treatment to continue with radiotherapy 
alone. The child was irradiated with VMAT tech-
nique with cone beam CT guidance (IGRT-image 
guided radiotherapy) to a total dose of 50.4Gy in 
1.8 Gy daily fractions for the nasopharynx, the bilat-
eral regional lymph nodes levels Ib-II-III-IV-V and 
retropharyngeal lymph nodesand the areas of initial 
extension of the tumor (Fig. 5). As the initial tumor 
was located retrobulbary next to the left optic nerve 
and left eye bulb, left lens, delivering high radiation 
dose will increase the risk of late toxicity,and taking 
in account the full metabolic tumor regression at 
PET CT, a decision for dose deescalation to 50.4Gy 
was made. No additional treatment was applied. 
On follow up imaging 3 months post radiotherapy, 
another MRI and PET/CT were performed. MRI 
showed further reduction of the size of the tumor 
(Fig. 6). PET/CT confirmed the soft tissue thicken-
ing with no metabolic activity at sphenoidal sinus, 
left ethmoidal cells, posterior wall of left maxillary 
sinus, but detected solitary osteolytic bone lesions in 
left ischiadic bone. Further MRI of the pelvis was 
perform. The progression of the disease was proved 
4 months post end of treatment.
Discussion
NPC in children is often diagnosed in locoregional 
advanced stage [1]. For best initial evaluation of 
tumor spread two imaging modality have shown to 
be of value [6, 7]. MRI give us correct definition 
of T an N category, but PET/CT could early detect 
distant metastasis [7, 8]. They both are used also 
for treatment follow up. The implementation of 
follow up PET/CT in the present case enabled early 
detectection of distant metastasis.
The preferred treatment protocol for advanced 
childhood NPC is the one used at the prospective, 
multicenter study NPC-2003-GPOH/DCOG [4, 6]. 
It includes 3 courses of neoadjuvant chemotherapy 
with cisplatin, 5-fluorouracil, and folinic acid fol-
lowed by chemoradiation, andinterferon betatreat-
ment for six months. The cumulative irradiation 
dose was 54 Gy inpatients with complete remission 
after neoadjuvant chemotherapy, and 59.4 Gy in 
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not full responders. After a median follow-up of 30 
months (range, 6-95 months), the reported event 
free survival and the overall survival are respec-
tively 92.4% and 97.1% with no severe toxicity. 
These are the best reported results but still many 
answers are there to be answered. If reduction 
of the dose in good responders is suitable for all 
patients, or couldthe concomitant chemotherapy be 
omitted and further reduce the rate ofearly and late 
morbidity. Randomize trials are needed.
NPC-2003-GPOH/DCOG study together with two 
more were the first exploring dose deescalation and 
proved that is feasible [4-6]. The total radiation 
dose used earlier were in the range of 66-70Gy at a 
price of high toxicity [1]. For further reduction of 
toxicity advanced radiotherapy techniques as IMRT 
[9] and his advanced type VMATand IGRT are in 
use. IMRT and VMAT enable precisely delivery of 
the maximum dose only at the target with simul-
taneous decrease the dose at organs at risk. And 
IGRT with cone beam computer tomography imag-
ing in treatment room help us every day to visual-
ize the target volume and not to miss the target, so 
accurate delivery. The combination of VMAT and 
IGRT could further contribute for improving tumor 
control and reducing toxicity.
Investigation of Epstein Barr virus is recommended 
as it could serve as prognostic and predictive 
marker [6].
With the present paper a high-risk childhood undif-
ferentiated NPC is presented. Diagnostic MRI and 
PET/CT were performed with good concordance for 
primary tumor extension and lymph node involve-
ment. At presentation and no distant metastasis 
were detected. Three coursesinduction chemother-
apy were applied according to NPC2003-GPOH 
protocolwith good treatment response. The restag-
ing PET/CT found no distant metastasis. Deescala-
tion protocol radiotherapy alone was delivered to 
50.4Gy total dose with IGRT VMAT irradiation 
technique. No interferon beta was applied.At three 
month PET/CT follow up a solitary bone lesion was 
detected. 
The reason for distant failure could be explained be 
the advance stage,the low radiation dose compared 
to 70Gy, no concomitant chemotherapy with radio-
therapy or the lack of interferon beta treatment. The 
weakness of the treatment is the lack of Epstain Barr 
viral infection evaluation. Although radiation dose 
was comparably low an excellent local control was 
achieved. The lack of concomitant chemotherapy 
could be a better explanation for distant failure, but it 
was not applied because of the potential hematologi-
cal toxicity, which was observed in the patient with 
radiotherapy alone. This case shows the importance 
or PET/CT like imaging modality for follow up for 
early detection of distant failure. MRI still keeps 
it role for best imaging modality for locoregional 
evaluation of the tumor spread.
Conclusion
The present case proved that in high risk patients 
more aggressive treatment strategies should be rec-
ommended with no omission of concurrent chemo-
therapy even after full response. Investigation for 
Epstein Barr virus infection is mandatory and IFN 
beta treatment should be explored. Deescalation 
of radiotherapy probably is not appropriate in this 
group of patients, no matter the excellent response 
to induction chemotherapy. The higher late mor-
bidity risk should be accepted in order to eradicate 
the disease. MRI and PET CT should be used as 
complementary imaging modalities for early detec-
tion of locoregional or distant metastasis. Random-
ize trials are warranted to answer in which patients 
deescalation of radiation dose and omission of 
concurrent chemotherapy is reasonable even with 
the implementation of advanced IMRT techniques 
like VMAT and set a certain unified international 
guidelines for treatment improvements.
Fig. 1. Diagnostic MRI before treatment
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Fig. 2. Diagnostic PET/CT before treatment
  
Fig. 3. Control MRI after 3 courses induction chemotherapy before radiotherapy
Fig. 4. Control PET/CT after 3 courses induction chemotherapy before radiotherapy
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Fig. 5. VMAT radiotherapy treatment plan
  
Fig. 6. Follow up MRI3 months post radiotherapy
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